Type 2 Diabetes Mellitus

• CLINICAL_TRIALS trial_result · 2022-05-04
  Clinical Trial Update: Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus [Phase 3]

  Phase 3 trial evaluating liraglutide for cognitive function improvement in patients with Type 2 diabetes mellitus has completed.

• CLINICAL_TRIALS trial_result · 2022-05-04
  Clinical Trial Update: Monitoring Parameters Beyond Glycemic Control: Impact of Sitagliptin on Quality of Life in Type 2 Diabetes Patients [Phase 4]

  Phase 4 trial update evaluating sitagliptin's impact on quality of life in Type 2 diabetes patients, beyond glycemic control.

• CLINICAL_TRIALS trial_result · 2022-05-04
  Clinical Trial Update: A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes [Phase 3]

  A Phase 3 trial comparing semaglutide to insulin aspart, both with metformin and insulin glargine, in Type 2 diabetes has completed with pos…

• CLINICAL_TRIALS trial_result · 2022-05-03
  Clinical Trial Update: The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 Diabetes [Phase 2]

  Phase 2 trial investigating the metabolic, metabolomic, and microbiome effects of bariatric surgery in patients with type 2 diabetes and obe…

• CLINICAL_TRIALS trial_result · 2022-05-03
  Clinical Trial Update: Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes Mellitus [Phase 4]

  A Phase 4 clinical trial compared empagliflozin and vildagliptin in adults with type 2 diabetes and has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-04-29
  Clinical Trial Update: A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With Diabetes [Phase 2]

  Phase 2 trial investigating 4 weeks of dosing with XEN-D0501 for blood glucose reduction in adults with type 2 diabetes; study completed.

• CLINICAL_TRIALS trial_result · 2022-04-25
  Clinical Trial Update: Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM) [Phase 3]

  Phase 3 trial update evaluating the efficacy and safety of the insulin glargine/lixisenatide combination (Soliqua) in adults with type 2 dia…

• CLINICAL_TRIALS trial_result · 2022-04-25
  Clinical Trial Update: Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy [Phase 3]

  Phase 3 trial comparing a new formulation of insulin glargine with Lantus in patients with Type 2 diabetes not adequately controlled on non-…

• CLINICAL_TRIALS trial_result · 2022-04-25
  Clinical Trial Update: Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India) [Phase 3]

  Phase 3 trial comparing the fixed ratio combination of insulin glargine/lixisenatide versus insulin glargine in type 2 diabetes; results com…

• CLINICAL_TRIALS trial_result · 2022-04-25
  Clinical Trial Update: Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive [Phase 4]

  A Phase 4 trial comparing alogliptin to acarbose in Chinese patients with type 2 diabetes and high cardiovascular risk on aspirin and inadeq…

• CLINICAL_TRIALS trial_result · 2022-04-25
  Clinical Trial Update: Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Diet and Exercise [Phase 3]

  Phase 3 trial update comparing sotagliflozin to placebo in Chinese patients with type 2 diabetes not adequately controlled by diet and exerc…

• CLINICAL_TRIALS trial_result · 2022-04-25
  Clinical Trial Update: Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy [Phase 4]

  A Phase 4 trial comparing two treatment regimens in adults with type 2 diabetes after short-term intensive insulin therapy has completed.

• CLINICAL_TRIALS trial_result · 2022-04-25
  Clinical Trial Update: Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL) [Phase 4]

  Phase 4 trial update assessing three fasting plasma glucose targets in Chinese patients with Type 2 diabetes mellitus.

• CLINICAL_TRIALS trial_result · 2022-04-25
  Clinical Trial Update: Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of Insulin [Phase 4]

  Phase 4 trial evaluating the efficacy and safety of insulin glargine 300 U/mL in adults with type 2 diabetes mellitus inadequately controlle…

• CLINICAL_TRIALS trial_result · 2022-04-25
  Clinical Trial Update: Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without Sulfonylurea [Phase 3]

  Phase 3 trial evaluating sotagliflozin vs placebo in Chinese patients with Type 2 diabetes mellitus inadequately controlled by metformin +/-…

• CLINICAL_TRIALS trial_result · 2022-04-25
  Clinical Trial Update: Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) [Phase 4]

  Phase 4 trial comparing standard versus higher starting dose of insulin glargine in Chinese patients with Type 2 diabetes.

• CLINICAL_TRIALS trial_result · 2022-04-25
  Clinical Trial Update: Evaluation of Toujeo Insulin in Type 2 Diabetes Patients Inadequately Control With Their Basal Insulin Treatment [Phase 4]

  Phase 4 clinical trial evaluating Toujeo Insulin in type 2 diabetes patients inadequately controlled with basal insulin.

• CLINICAL_TRIALS trial_result · 2022-04-25
  Clinical Trial Update: Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderate Hypertension [Phase 2]

  Phase 2 trial comparing pharmacodynamic effects of sotagliflozin vs empagliflozin in type 2 diabetes patients with mild to moderate hyperten…

• CLINICAL_TRIALS trial_result · 2022-04-25
  Clinical Trial Update: Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan [Phase 4]

  Phase 4 trial assessing safety of lixisenatide added to sulfonylurea and basal insulin in type 2 diabetes patients who fast during Ramadan.

• CLINICAL_TRIALS trial_result · 2022-04-25
  Clinical Trial Update: A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulin in Patients Already Using Basal Insulin [Phase 4]

  Phase 4 real-world trial comparing Toujeo to standard of care basal insulin in patients with type 2 diabetes has completed.

• CLINICAL_TRIALS research · 2022-04-25
  Clinical Trial Update: A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulins in Insulin Naïve Patients Initiating Insulin [Phase 4]

  A Phase 4 trial comparing Toujeo to standard basal insulins in insulin-naïve type 2 diabetes patients has completed.

• CLINICAL_TRIALS trial_result · 2022-04-22
  Clinical Trial Update: Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy [Phase 3]

  Phase 3 trial evaluating PB-201 in Type 2 diabetes patients with poor glycemic control on metformin monotherapy.

• CLINICAL_TRIALS trial_result · 2022-04-20
  Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Evaluate the Clinical Efficacy and Safety of Yogliptin Tablets [Phase 3]

  Phase 3 randomized trial evaluating the efficacy and safety of Yogliptin tablets for type 2 diabetes.

• CLINICAL_TRIALS trial_result · 2022-04-20
  Clinical Trial Update: Evaluation of the Ottawa Model for Smoking Cessation in Diabetes Education Programs [NA]

  Clinical trial update evaluating the Ottawa Model for Smoking Cessation within diabetes education programs; completed with posted results.

• CLINICAL_TRIALS trial_result · 2022-04-19
  Clinical Trial Update: Blueberry Consumption and Type 2 Diabetes [NA]

  Completed clinical trial evaluating blueberry consumption in individuals with Type 2 Diabetes; results posted in 2022.